In this episode, Dr. Daniel Wilinski, CEO of Keryx, shares his journey from academia to entrepreneurship. Dr. Wilinski discusses the challenges and rewards of transitioning from running a research lab to leading a biotech company, emphasizing the importance of leveraging academic skills in a business context. He also offers advice to aspiring entrepreneurs, encouraging them to pursue their passions and utilize available resources to propel them forward. The conversation highlights the differences between academic and business environments, focusing on the need for adaptability and continuous learning.

"The training I received as a postdoc set me up well to run a company."

Dr. Daniel Wilinski

Daniel Wilinski graduated with a PhD in cellular and molecular biology from the University of Wisconsin in 2015. He completed his postdoctoral training at the University of Michigan in 2024 where he was awarded a National Research Service Award (NRSA) T32 Award and a Pathway to Independence (K99/R00) Award from NIH. Daniel is currently the founder and CEO of Keryx, where he develops breakthrough RNA therapeutics that prevent diabetes at a cellular level. As a fun fact, Daniel taught Biology in Tanzania for 2 years.

Connect with Daniel on LinkedIn